FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 317

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
IMCR Nasdaq Immunocore Holdings plc 2836
IMDX Nasdaq Insight Molecular Diagnostics Inc. 2836
IMUX Nasdaq Immunic, Inc. 2836
IMVT Nasdaq Immunovant, Inc. 2836
INAB Nasdaq IN8bio, Inc. 2836
INBX Nasdaq Inhibrx Biosciences, Inc. 2836
INCY Nasdaq Incyte Corporation 2836
INM Nasdaq InMed Pharmaceuticals Inc. 2836
INMB Nasdaq INmune Bio, Inc. 2836
INO Nasdaq Inovio Pharmaceuticals, Inc. 2836
INSM Nasdaq Insmed Incorporated 2836
IOVA Nasdaq Iovance Biotherapeutics, Inc. 2836
IPSC Nasdaq Century Therapeutics, Inc. 2836
IRD Nasdaq Opus Genetics, Inc. 2836
IRWD Nasdaq Ironwood Pharmaceuticals, Inc. 2836
IVA Nasdaq Inventiva S.A. 2836
IVVD Nasdaq Invivyd, Inc. 2836
JBIO Nasdaq Jade Biosciences, Inc. 2836
JSPR Nasdaq Jasper Therapeutics, Inc. 2836
KALA Nasdaq KALA BIO, Inc. 2836
KLRS Nasdaq Kalaris Therapeutics, Inc. 2836
KROS Nasdaq Keros Therapeutics, Inc. 2836
KRRO Nasdaq Korro Bio, Inc. 2836
KYMR Nasdaq Kymera Therapeutics, Inc. 2836
KYTX Nasdaq Kyverna Therapeutics, Inc. 2836
KZR Nasdaq Kezar Life Sciences, Inc. 2836
LCTX NYSE American Lineage Cell Therapeutics, Inc. 2836
LEGN Nasdaq Legend Biotech Corporation 2836
LGND Nasdaq Ligand Pharmaceuticals Incorporated 2836
LGVN Nasdaq Longeveron Inc. 2836
LIXT Nasdaq Lixte Biotechnology Holdings, Inc. 2836
LNAI Nasdaq Lunai Bioworks Inc. 2836
LVTX Nasdaq LAVA Therapeutics N.V. 2836
LXRX Nasdaq Lexicon Pharmaceuticals, Inc. 2836
LYEL Nasdaq Lyell Immunopharma, Inc. 2836
MAIA NYSE American MAIA Biotechnology, Inc. 2836
MBIO Nasdaq Mustang Bio, Inc. 2836
MDXG Nasdaq MiMedx Group, Inc. 2836
MENS Nasdaq Jyong Biotech Ltd. 2836
MESO Nasdaq Mesoblast Limited 2836
MGNX Nasdaq MacroGenics, Inc. 2836
MLTX Nasdaq MoonLake Immunotherapeutics 2836
MNOV Nasdaq MediciNova, Inc. 2836
MNPR Nasdaq Monopar Therapeutics Inc. 2836
MREO Nasdaq Mereo BioPharma Group plc 2836
MRKR Nasdaq Marker Therapeutics, Inc. 2836
MRNA Nasdaq Moderna, Inc. 2836
MRUS Nasdaq Merus N.V. 2836
MYGN Nasdaq Myriad Genetics, Inc. 2836
NBIX Nasdaq Neurocrine Biosciences, Inc. 2836
Results 150 through 200 of 317